Company intelligence / Profile preview

Avantis Medical Systems

San Jose, California, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~1
Development stage: Commercial

Overview

The Third Eye Retroscope has been clinically proven to significantly increase adenoma detection rates compared to standard colonoscopy—helping physicians find up to 23–25% more adenomas overall, and over 40% additional adenomas in higher-risk patients. The device was supported by six randomized trials in the field.

Therapeutic areas: OncologyGastroenterology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

PENTAX Medical – distribution partnership for U.S. commercialization of the Third Eye Panoramic Imaging System.Oxford Finance – financial partner/lender.

Beyond the preview

Go deeper on Avantis Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avantis Medical Systems.

Explore the full profile